MyAverix Finance
SHG · Healthcare
Gan & Lee Pharmaceuticals Co Ltd (603087)
Medical Instruments & Supplies
Gan & Lee Pharmaceuticals Co Ltd (603087) is listed on SHG in the Healthcare sector. Industry: Medical Instruments & Supplies. As of 2026-03-28, reported market cap is $36.87B, P/E ratio is 39.32, net margin is 24.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603087
Gan & Lee Pharmaceuticals Co Ltd (603087) — FAQ
What is Gan & Lee Pharmaceuticals Co Ltd's market cap?
Gan & Lee Pharmaceuticals Co Ltd (603087) has a reported market cap of $36.87B (data as of 2026-03-28).
What is 603087's P/E ratio?
The price-to-earnings (P/E) ratio for Gan & Lee Pharmaceuticals Co Ltd (603087) is 39.32 (data as of 2026-03-28).
Does Gan & Lee Pharmaceuticals Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Gan & Lee Pharmaceuticals Co Ltd (603087). Check the MyAverix Finance app for the latest dividend data.
What sector is Gan & Lee Pharmaceuticals Co Ltd in?
Gan & Lee Pharmaceuticals Co Ltd (603087) is classified in the Healthcare sector (Medical Instruments & Supplies industry).
What exchange is 603087 listed on?
603087 is listed on SHG.
What is Gan & Lee Pharmaceuticals Co Ltd's net margin?
Gan & Lee Pharmaceuticals Co Ltd (603087) reports a net margin of 24.1% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.